LOAMU
EDIT icon

Lombard Odier Asset Management (USA)’s Editas Medicine EDIT Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50,000
Closed -$1.59M – 242
2018
Q3 		$1.59M Buy
+50,000
New +$1.62M 0.12% 165

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s EDIT Position: Q4 2018 in Review

Lombard Odier Asset Management (USA) sold out of Editas Medicine (EDIT) in Q4 2018, closing a stake of 50,000 shares — an estimated $1.59M sold.

Lombard Odier Asset Management (USA) first reported a position in EDIT in Q3 2018 and held it in 1 quarter. The position peaked at $1.59M in Q3 2018. 194 funds tracked by Wall St. Rank hold EDIT as of Q4 2018.

  • Lombard Odier Asset Management (USA) reported no remaining Editas Medicine position as of Q4 2018 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 50,000 Editas Medicine shares in Q4 2018, an estimated $1.59M.
  • Lombard Odier Asset Management (USA) first reported a position in Editas Medicine in Q3 2018 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s Editas Medicine position peaked at $1.59M in Q3 2018.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2018.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2018, filed 14 Feb 2019.